AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levings, R. S.
Right arrow Articles by Djordjevic, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levings, R. S.
Right arrow Articles by Djordjevic, S. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2006, p. 3514-3515, Vol. 50, No. 10
0066-4804/06/$08.00+0     doi:10.1128/AAC.00817-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

linG, a New Integron-Associated Gene Cassette Encoding a Lincosamide Nucleotidyltransferase


   LETTER
Top
 Letter
Nucleotide sequence accession...
 References
 
Lincosamide antibiotics include lincomycin, a compound produced by several actinomycetes, and its semisynthetic chlorinated derivative clindamycin. These antibiotics block the peptidyltransferase activity of the 50S subunit of the bacterial ribosome, inhibiting protein synthesis, and are active against most gram-positive cocci and anaerobes. However, they are not generally effective against gram-negative bacilli due to intrinsic resistance (3, 5).

Resistance to lincosamides is most commonly due to N6 dimethylation of an adenine residue in the 23S rRNA, which usually confers broad-spectrum cross-resistance to macrolides, lincosamides, and streptogramin B antibiotics or to efflux (5). However, antibiotic inactivation by nucleotidylation (1, 2) has also been described as a mechanism of resistance. Despite the fact that lincosamides are not used to treat enterobacterial infections, a gene, linF, that confers low levels of resistance to both lincomycin (fourfold) and clindamycin (twofold) was recently found in a gene cassette in a class 1 integron recovered from an Escherichia coli blood isolate (4). The linF gene encodes a 273-amino-acid lincosamide nucleotidyltransferase. The LinF protein shares approximately 35% identity with the nucleotidyltransferases encoded by the linB gene from Enterococcus faecium (1) (GenBank accession no. AF110130) and linB' from Enterococcus faecalis (GenBank accession no. AF408195).

We have identified a second lin gene in a gene cassette. This cassette was recovered from a multiply antibiotic-resistant Salmonella enterica serovar Stanley strain (SRC54) isolated in 2001 from a traveler who had recently returned from Thailand. This strain was resistant to chloramphenicol, gentamicin, kanamycin, spectinomycin, streptomycin, sulfathiazole, and tetracycline but susceptible to ampicillin and nalidixic acid at levels described previously (6). It displayed intermediate resistance to ciprofloxacin. The gene cassette array was amplified by using standard primers (L2 and R1) in the 5' conserved sequence and 3' conserved sequence of class 1 integrons, and the 2.25-kb amplicon was cloned into pPCRscript and sequenced as previously described (see reference 6 for primer details). E. coli strain DH5{alpha} containing pPCR-Script with the cassette array was at least 10-fold more resistant to lincomycin (MIC, ≥2,000 µg/ml) than DH5{alpha} containing only pPCR-Script (MIC, 180 µg/ml).

The first cassette in the array was identical to the aadA2 cassette in GenBank accession no. L06822. The second cassette was 937 bp long and 93.4% identical to the linF gene cassette. It encoded a 273-amino-acid protein that is 93.1% identical to LinF (17 amino acid differences). An alignment of these proteins with LinB is shown in Fig. 1A. The sequence of the aadA2-linG cassette array was identical to a region found in GenBank accession no. AY522431. The 59-base elements (59-be; attC sites) of the linG and linF cassettes are 58 bp long (Fig. 1B) and not closely related to any other known 59-be. They retain the critical features of 59-be, namely, complementary sites 1L-1R and 2L-2R (7).


Figure 1
View larger version (61K):
[in this window]
[in a new window]
  		FIG. 1. Analysis of LinG sequences. (A) Alignment of Lin proteins. Amino acids that are completely conserved across all sequences are shown as white letters on a black background. The protein sequences of LinB and LinF were from GenBank accession numbers AF110130 and AJ561197, respectively. The LinG protein sequence is from this study. (B) Alignment of linF and linG 59-be. The core sites are in bold and are labeled 1L, 1R, 2L, and 2R (7). The boundaries of the LH (left-hand) and RH (right-hand) simple sites and the 59-be are indicated by bars. The bases in lowercase are those derived from the beginning of the cassette. The stop codons of the LinG and LinF proteins are indicated by the asterisk. The sequence of each 59-be came from the sources mentioned for panel A.

 

   Nucleotide sequence accession numbers.
Top
 Letter
 Nucleotide sequence accession...
References
 
The sequence of the aadA2-linG cassette array has been deposited in GenBank under accession no. DQ836009.


   REFERENCES
Top
 Letter
 Nucleotide sequence accession...
 References
 

  1. Bozdogan, B., L. Berrezouga, M. Kuo, D. A. Yurek, K. A. Farley, B. J. Stockman, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43:925-929.[Abstract/Free Full Text]
  2. Brisson-Noel, A., P. Delrieu, D. Samain, and P. Courvalin. 1988. Inactivation of lincosamide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes. J. Biol. Chem. 263:15880-15887.[Abstract/Free Full Text]
  3. Dhawan, V. K., and H. Thadepalli. 1982. Clindamycin: a review of fifteen years of experience. Rev. Infect. Dis. 4:1133-1153.[Medline]
  4. Hier, E., B.-A. Lindstedt, T. M. Leegaard, E. Gjernes, and G. Kapperud. 8 July 2004. Prevalence and characterization of integrons in blood culture Enterobacteriaceae and gastrointestinal Escherichia coli in Norway and reporting of a novel class 1 integron-located lincosamide resistance gene. Ann. Clin. Microbiol. Antimicrob. 3:12. doi:10.1186/1476-0711-3-12.[CrossRef][Medline]
  5. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.[CrossRef][Medline]
  6. Levings, R. S., S. R. Partridge, D. Lightfoot, R. M. Hall, and S. P. Djordjevic. 2005. New integron-associated gene cassette encoding a 3-N-aminoglycoside acetyltransferase. Antimicrob. Agents Chemother. 49:1238-1241.[Abstract/Free Full Text]
  7. Stokes, H. W., D. B. O'Gorman, G. D. Recchia, M. Parsekhian, and R. M. Hall. 1997. Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol. Microbiol. 26:731-745.[CrossRef][Medline]
Renee S. Levings
New South Wales Department of Primary Industries
Elizabeth Macarthur Agricultural Institute
Microbiology and Immunology Section
Camden, New South Wales 2570, Australia

Ruth M. Hall
School of Molecular and Microbial Biosciences
The University of Sydney
Sydney, New South Wales 2006, Australia,1

Diane Lightfoot
Microbiological Diagnostic Unit
Public Health Laboratory
Department of Microbiology and Immunology
University of Melbourne
Melbourne, Victoria 3010, Australia,2

Steven P. Djordjevic*
New South Wales Department of Primary Industries
Elizabeth Macarthur Agricultural Institute
Microbiology and Immunology Section
Camden, New South Wales 2570, Australia,3

* Phone: (612) 46-406426, Fax: (612) 46-406384, E-mail: steve.djordjevic{at}dpi.nsw.gov.au

Antimicrobial Agents and Chemotherapy, October 2006, p. 3514-3515, Vol. 50, No. 10
0066-4804/06/$08.00+0     doi:10.1128/AAC.00817-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levings, R. S.
Right arrow Articles by Djordjevic, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levings, R. S.
Right arrow Articles by Djordjevic, S. P.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS